Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.

Hernández-Bernal F, Subirós-Martínez N, Gutiérrez-Ronquillo JH, Colina-Ávila E, Guevara-Rodríguez M, Estenoz-García D, Catasús-Álvarez K, Martín-Bauta Y, Pérez-Saad H, Manso-López AM, Batista-Izquierdo A, González-Dalmau E, Amador-Nuñez T, Muzio-González VL, Guillén-Nieto GE, Garcia-Del-Barco-Herrera D, COURAGE COmbined therapeUtic appRoAch durinG acute strokE Research Group

Open source

DOI
10.1016/j.jocn.2026.112195
Published
2026 Oct
Container
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jocn.2026.112195,
  title = {Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.},
  author = {Hernández-Bernal F and Subirós-Martínez N and Gutiérrez-Ronquillo JH and Colina-Ávila E and Guevara-Rodríguez M and Estenoz-García D and Catasús-Álvarez K and Martín-Bauta Y and Pérez-Saad H and Manso-López AM and Batista-Izquierdo A and González-Dalmau E and Amador-Nuñez T and Muzio-González VL and Guillén-Nieto GE and Garcia-Del-Barco-Herrera D and COURAGE COmbined therapeUtic appRoAch durinG acute strokE Research Group},
  year = {2026},
  journal = {Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia},
  doi = {10.1016/j.jocn.2026.112195},
  url = {https://doi.org/10.1016/j.jocn.2026.112195}
}

RIS

TY  - JOUR
TI  - Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.
AU  - Hernández-Bernal F
AU  - Subirós-Martínez N
AU  - Gutiérrez-Ronquillo JH
AU  - Colina-Ávila E
AU  - Guevara-Rodríguez M
AU  - Estenoz-García D
AU  - Catasús-Álvarez K
AU  - Martín-Bauta Y
AU  - Pérez-Saad H
AU  - Manso-López AM
AU  - Batista-Izquierdo A
AU  - González-Dalmau E
AU  - Amador-Nuñez T
AU  - Muzio-González VL
AU  - Guillén-Nieto GE
AU  - Garcia-Del-Barco-Herrera D
AU  - COURAGE COmbined therapeUtic appRoAch durinG acute strokE Research Group
PY  - 2026
JO  - Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
DO  - 10.1016/j.jocn.2026.112195
UR  - https://doi.org/10.1016/j.jocn.2026.112195
ER  - 

APA

F, H., N, S., JH, G., E, C., M, G., D, E., K, C., Y, M., H, P., AM, M., A, B., E, G., T, A., VL, M., GE, G., D, G., & Group, C. C. T. A. D. A. S. R. (2026). Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. https://doi.org/10.1016/j.jocn.2026.112195

Source records